These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36698902)

  • 1. Newborn screening for X-linked adrenoleukodystrophy in Italy: Diagnostic algorithm and disease monitoring.
    Bonaventura E; Alberti L; Lucchi S; Cappelletti L; Fazzone S; Cattaneo E; Bellini M; Izzo G; Parazzini C; Bosetti A; Di Profio E; Fiore G; Ferrario M; Mameli C; Sangiorgio A; Masnada S; Zuccotti GV; Veggiotti P; Spaccini L; Iascone M; Verduci E; Cereda C; Tonduti D;
    Front Neurol; 2022; 13():1072256. PubMed ID: 36698902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan.
    Chen HA; Hsu RH; Chen PW; Lee NC; Chiu PC; Hwu WL; Chien YH
    Mol Genet Metab Rep; 2022 Sep; 32():100902. PubMed ID: 36046390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
    Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
    Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific newborn screening for X-linked adrenoleukodystrophy.
    Albersen M; van der Beek SL; Dijkstra IME; Alders M; Barendsen RW; Bliek J; Boelen A; Ebberink MS; Ferdinandusse S; Goorden SMI; Heijboer AC; Jansen M; Jaspers YRJ; Metgod I; Salomons GS; Vaz FM; Verschoof-Puite RK; Visser WF; Dekkers E; Engelen M; Kemp S
    J Inherit Metab Dis; 2023 Jan; 46(1):116-128. PubMed ID: 36256460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aicardi-Goutières syndrome may present with positive newborn screen for X-linked adrenoleukodystrophy.
    Tise CG; Morales JA; Lee AS; Velez-Bartolomei F; Floyd BJ; Levy RJ; Cusmano-Ozog KP; Feigenbaum AS; Ruzhnikov MRZ; Lee CU; Enns GM
    Am J Med Genet A; 2021 Jun; 185(6):1848-1853. PubMed ID: 33683010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.
    Turgeon CT; Moser AB; Mørkrid L; Magera MJ; Gavrilov DK; Oglesbee D; Raymond K; Rinaldo P; Matern D; Tortorelli S
    Mol Genet Metab; 2015 Jan; 114(1):46-50. PubMed ID: 25481105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
    Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
    Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Newborn screening for X-linked adrenoleukodystrophy in Italy: diagnostic algorithm and disease monitoring.
    Bonaventura E; Alberti L; Lucchi S; Cappelletti L; Fazzone S; Cattaneo E; Bellini M; Izzo G; Parazzini C; Bosetti A; Di Profio E; Fiore G; Ferrario M; Mameli C; Sangiorgio A; Masnada S; Zuccotti GV; Veggiotti P; Spaccini L; Iascone M; Verduci E; Cereda C; Tonduti D;
    Front Neurol; 2024; 15():1376447. PubMed ID: 38510379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn Screening for X-Linked Adrenoleukodystrophy (X-ALD): Biochemical, Molecular, and Clinical Characteristics of Other Genetic Conditions.
    Mares Beltran CF; Tise CG; Barrick R; Niehaus AD; Sponberg R; Chang R; Enns GM; Abdenur JE
    Genes (Basel); 2024 Jun; 15(7):. PubMed ID: 39062617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening.
    Haynes CA; De Jesús VR
    Clin Chim Acta; 2012 Aug; 413(15-16):1217-21. PubMed ID: 22503909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow injection ionization-tandem mass spectrometry-based estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
    Natarajan A; Christopher R; Netravathi M; Bhat MD; Chandra SR
    Clin Chim Acta; 2019 Aug; 495():167-173. PubMed ID: 30980791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn Screen for X-Linked Adrenoleukodystrophy Using Flow Injection Tandem Mass Spectrometry in Negative Ion Mode.
    Teber TA; Conti BJ; Haynes CA; Hietala A; Baker MW
    Int J Neonatal Screen; 2022 Apr; 8(2):. PubMed ID: 35466198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a diagnostic methodology by quantification of 26:0 lysophosphatidylcholine in dried blood spots for Japanese newborn screening of X-linked adrenoleukodystrophy.
    Wu C; Iwamoto T; Igarashi J; Miyajima T; Hossain MA; Yanagisawa H; Akiyama K; Shintaku H; Eto Y
    Mol Genet Metab Rep; 2017 Sep; 12():115-118. PubMed ID: 28725571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography-tandem mass spectrometry method for estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
    Natarajan A; Christopher R; Netravathi M; Bhat M; Chandra SR
    Clin Chim Acta; 2018 Oct; 485():305-310. PubMed ID: 30018013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn Screening for X-Linked Adrenoleukodystrophy in Nebraska: Initial Experiences and Challenges.
    Baker CV; Cady Keller A; Lutz R; Eveans K; Baumert K; DiPerna JC; Rizzo WB
    Int J Neonatal Screen; 2022 Apr; 8(2):. PubMed ID: 35645283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.
    Lee S; Clinard K; Young SP; Rehder CW; Fan Z; Calikoglu AS; Bali DS; Bailey DB; Gehtland LM; Millington DS; Patel HS; Beckloff SE; Zimmerman SJ; Powell CM; Taylor JL
    JAMA Netw Open; 2020 Jan; 3(1):e1920356. PubMed ID: 32003821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.
    Armangue T; Orsini JJ; Takanohashi A; Gavazzi F; Conant A; Ulrick N; Morrissey MA; Nahhas N; Helman G; Gordish-Dressman H; Orcesi S; Tonduti D; Stutterd C; van Haren K; Toro C; Iglesias AD; van der Knaap MS; Goldbach Mansky R; Moser AB; Jones RO; Vanderver A
    Mol Genet Metab; 2017 Nov; 122(3):134-139. PubMed ID: 28739201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders.
    Jaspers YRJ; Ferdinandusse S; Dijkstra IME; Barendsen RW; van Lenthe H; Kulik W; Engelen M; Goorden SMI; Vaz FM; Kemp S
    Front Cell Dev Biol; 2020; 8():690. PubMed ID: 32903870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China.
    Tian GL; Xu F; Jiang K; Wang YM; Ji W; Zhuang YP
    Clin Chim Acta; 2020 Apr; 503():157-162. PubMed ID: 31978407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very long chain acylcarnitines and lysophosphatidylcholines in screening of peroxisomal disease in children by tandem mass spectrometry.
    Wang Y; Tian G; Ji W; Wang S; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):481-486. PubMed ID: 34704420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.